Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial [Phase 3]
This clinical trial update describes two Phase 3 studies within the PREDICT-RT trial for high-risk prostate cancer, testing reduced-intensit…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents [Phase 3]
Phase 3 trial evaluating Saruparib (AZD5305) versus placebo in men with metastatic castration-sensitive prostate cancer receiving physician'…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging [Phase 3]
A Phase 3 trial is evaluating the combination of apalutamide with PET-guided targeted radiation for men with prostate cancer that has recurr…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer [Phase 1]
A Phase 1 pilot study evaluating ultra-high-dose hypofractionated or single-dose radiotherapy for intermediate-risk prostate cancer; the tri…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC) [Phase 1, Phase 2]
A Phase I/II clinical trial is evaluating the combination of ADI-PEG20 with carboplatin and cabazitaxel for aggressive variant prostate canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial of ZM008, an anti-LLT1 antibody, given as a single agent and then in combination with toripalimab in patients with ad…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating ASP5541 in participants with prostate cancer, including metastatic castration-resistant and metastatic h…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro) [Phase 2]
Phase 2 trial evaluating terbinafine for biochemically recurrent prostate cancer. The study is currently recruiting in Switzerland.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Veteran Peer Navigators to Promote Shared Decision Making for PSA Screening [NA]
This clinical trial update describes a VA-supported effort to use Veteran Peer Navigators to promote shared decision making around PSA scree…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function [NA]
Clinical trial evaluating Lutetium-177 PSMA therapy in patients with compromised renal and/or bone marrow function is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Active Surveillance SNEP Assay Registry Trial for Prostate Cancer
This is an active registry trial evaluating the SNEP assay for active surveillance in prostate cancer, with recruitment ongoing to assess di…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: VR Discharge Education After Prostatectomy [NA]
This completed clinical trial evaluated VR-based discharge education after prostatectomy.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency [Phase 3]
Phase 3 trial update evaluating the combination of capivasertib and abiraterone for patients with metastatic hormone-sensitive prostate canc…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan [Phase 2]
A Phase 2 clinical trial in Japan evaluating 177Lu-PSMA-617 for metastatic castration-resistant prostate cancer is sponsored by Novartis and…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/Phase 2 study of combining nivolumab immunotherapy with radiation therapy and androgen depriv…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Clinical Trial of Green Tea Catechins in Men on Active Surveillance [Phase 2]
A Phase 2 clinical trial update evaluating green tea catechins for men with prostate cancer on active surveillance; the study is currently a…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy. [NA]
The study evaluated a multimodal prehabilitation program before robotic-assisted radical prostatectomy in prostate cancer patients. The tria…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer. [Phase 2]
A Phase 2 diagnostic trial evaluates a fully hybrid 18F-PSMA PET/MRI approach as a one-stop method to diagnose clinically significant prosta…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors [NA]
A clinical trial is evaluating a mobile health app to improve quality-of-life outcomes for Black prostate cancer survivors. The study is cur…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer [NA]
An update on the GET FIT Together trial evaluating a socially enhanced exercise program for older men with prostate cancer; the study is cur…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial [NA]
This clinical trial update describes MATCH-UP, a pragmatic cluster randomized trial evaluating telehealth-delivered cancer care at home for …
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617 [Phase 1]
Phase 1 trial comparing Lutetium-177 PSMA-617 with Actinium-225 PSMA-617 in prostate cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Effects of Muscadine Grape Extract in Men With Prostate Cancer on Androgen Deprivation Therapy [Phase 2]
A Phase 2 clinical trial evaluating muscadine grape extract in men with recurrent prostate cancer on androgen deprivation therapy has comple…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer [Phase 1]
A Phase 1 clinical trial evaluating enzalutamide in combination with relacorilant for prostate cancer has completed. The document summarizes…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in Martinique [NA]
A completed clinical trial update reporting the prevalence of the HOXB13 c.853delT mutation in prostate cancer patients in Martinique.